Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update

Memorial Sloan Kettering Cancer Center (MSK)

Status: Active, not recruiting

Conditions: Hip Fractures; Pathological Fracture; Hip Fracture Pathologic; Pathological Fracture of Hip

Treatments: Other: Data Collection and Analysis

Study type: Observational

Funder types: Other

Identifiers

NCT06935071

16-1122

Details and patient eligibility

About

This study will be based on a retrospective review of patients who received endoprosthetic reconstruction for pathologic fracture of the proximal femur. The objectives would be two-fold: (1) to compare rates ofambulation, pain, and survival to the historic cohort and (2) to identify predictors of ambulation in the current population.

Enrollment: 300 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants have received endoprosthetic reconstruction for pathologic fracture of the proximal femur

Exclusion criteria

• Participants with fractures greater than 3mm from the lesser trochanter
• Participants without histopathologic confirmation of tumor

Trial design

300 participants in 1 patient group

Participants who received endoprosthetic reconstruction

Description:

Participants have received endoprosthetic reconstruction for pathologic fracture of the proximal femur.

Treatment:

Other: Data Collection and Analysis